SUNSHINE BIOPHARMA INC (SBFM) Stock Analyst Earnings Estimates
NASDAQ:SBFM - Nasdaq - US8677817004 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.346M 1,806.14% | 24.093M 454.37% | 34.874M 44.75% | 46.105M 32.20% | 61.2M 32.74% | |
| EBITDA YoY % growth | -8.649M -256.17% | -4.636M 46.40% | -5.589M -20.55% | N/A | N/A | |
| EBIT YoY % growth | -8.674M -255.35% | -4.785M 44.84% | -5.812M -21.46% | -2.703M 53.49% | 1.53M 156.60% | |
| Operating Margin | -199.59% | -19.86% | -16.67% | -5.86% | 2.50% | |
| EPS YoY % growth | N/A | N/A | -51.88 84.11% | -0.58 98.88% | 0.08 114.04% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.09 90.23% | -0.05 94.90% |
| Revenue Q2Q % growth | 12.342M 46.32% | 13.26M 38.20% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -535.5K 51.60% | -270.3K 86.74% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 98.87% | -0.11 | % | |
| Q4 2024 Q2Q % growth | -1.00 99.00% | 0.11 | -1.11 | -991.27% |
| Q3 2024 Q2Q % growth | -0.94 98.83% | 9.18 | -10.12 | -110.24% |
| Q2 2024 Q2Q % growth | -9.94 | -7.55 | -2.39 | -31.69% |
| Q1 2024 Q2Q % growth | -40.00 | -21.22 | -18.78 | -88.54% |
| Q4 2023 Q2Q % growth | -100.00 | -61.20 | -38.80 | -63.40% |
| Q3 2023 Q2Q % growth | -80.00 -99,900.00% | -122.40 | 42.40 | 34.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 9.41M 1.15% | 11.424M | -2.014M | -17.63% |
| Q1 2025 Q2Q % growth | 8.901M 18.04% | % | ||
| Q4 2024 Q2Q % growth | 9.595M 24.93% | 12.75M | -3.155M | -24.75% |
| Q3 2024 Q2Q % growth | 8.435M 41.60% | 12.036M | -3.601M | -29.92% |
| Q2 2024 Q2Q % growth | 9.303M 67.29% | 9.18M | 123.07K | 1.34% |
| Q1 2024 Q2Q % growth | 7.541M 54.08% | 7.14M | 401K | 5.62% |
| Q4 2023 Q2Q % growth | 7.68M 94.94% | 6.222M | 1.458M | 23.44% |
| Q3 2023 Q2Q % growth | 5.957M 4,385.69% | 6.12M | -163K | -2.66% |
| Q2 2023 Q2Q % growth | 5.561M 3,599.87% | % | ||
| Q1 2023 Q2Q % growth | 4.894M 3,888.67% | % | ||
| Q4 2022 Q2Q % growth | 3.94M 4,529.61% | % | ||
| Q3 2022 Q2Q % growth | 132.8K 163.49% | % | ||
| Q2 2022 Q2Q % growth | 150.3K 184.12% | % | ||
| Q1 2022 Q2Q % growth | 122.7K 205.99% | % | ||
| Q4 2021 Q2Q % growth | 85.1K 203.93% | % | ||
| Q3 2021 Q2Q % growth | 50.4K 193.02% | % | ||
| Q2 2021 Q2Q % growth | 52.9K 248.03% | % | ||
| Q1 2021 Q2Q % growth | 40.1K 261.26% | % | ||
| Q4 2020 Q2Q % growth | 28K 164.15% | % | ||
| Q3 2020 Q2Q % growth | 17.2K 135.62% | % | ||
| Q2 2020 Q2Q % growth | 15.2K 406.67% | % | ||
| Q1 2020 Q2Q % growth | 11.1K 5,450.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | -177.03% |
| Revenue | 0% | N/A | 0% | -54.8% |